GGrantIndex
← Leaderboards

Yehenew M Agazie

West Virginia University

$3,908,639
Attributed
$3,908,639
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $498.7K · FY200522
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$3,908,639 · 6

By mechanism

R01$2,943,528 · 2
P20$965,111 · 4

Top collaborators

No co-investigators on record.

Most similar at West Virginia University

Same institution · by research overlap

Others in their field

Top investigators on “In Vivo

Research focus

In VivoCellsCell TransformationSignal PathwayEpidermal Growth Factor ReceptorSignal TransductionTumorMalignant NeoplasmsBaseCell ProliferationMediator Of Activation ProteinNeoplasm MetastasisTumor GrowthTissuesProtein Tyrosine PhosphataseFutureBreastPhosphorylation SiteProtein OverexpressionMolecularMutantMediatingOverexpressionEpithelial To Mesenchymal Transition

Grant awards (14)

Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer$336,263
R01 · FY2022 · CA · contact PI
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer$343,125
R01 · FY2021 · CA · contact PI
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer$343,125
R01 · FY2020 · CA · contact PI
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer$332,830
R01 · FY2019 · CA · contact PI
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer$343,125
R01 · FY2018 · CA · contact PI
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis$243,000
R01 · FY2011 · CA · contact PI
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis$250,515
R01 · FY2010 · CA · contact PI
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis$250,515
R01 · FY2009 · CA · contact PI
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis$250,515
R01 · FY2008 · CA · contact PI
SHP2-MEDIATED CROSS-TALK BETWEEN WNT AND EGFR/HER2 SIGNALING IN BREAST CANCER$243,230
P20 · FY2008 · RR · contact PI
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis$250,515
R01 · FY2007 · CA · contact PI
SHP2-MEDIATED CROSS-TALK BETWEEN WNT AND EGFR/HER2 SIGNALING IN BREAST CANCER$248,194
P20 · FY2007 · RR · contact PI
SHP2-MEDIATED CROSS-TALK BETWEEN WNT AND EGFR/HER2 SIGNALING IN BREAST CANCER$255,606
P20 · FY2006 · RR · contact PI
REGULATION OF CELL MORPHOLOGY AND TRANSFORMATION BY SHP2$218,081
P20 · FY2005 · RR